Pål Rongved

879 total citations
37 papers, 717 citations indexed

About

Pål Rongved is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Pål Rongved has authored 37 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Organic Chemistry and 8 papers in Oncology. Recurrent topics in Pål Rongved's work include Lanthanide and Transition Metal Complexes (6 papers), Cholesterol and Lipid Metabolism (5 papers) and Drug Transport and Resistance Mechanisms (5 papers). Pål Rongved is often cited by papers focused on Lanthanide and Transition Metal Complexes (6 papers), Cholesterol and Lipid Metabolism (5 papers) and Drug Transport and Resistance Mechanisms (5 papers). Pål Rongved collaborates with scholars based in Norway, France and United States. Pål Rongved's co-authors include Jo Klaveness, Marc Le Borgne, Zouhair Bouaziz, Saı̈d Yous, Samar Issa, E. Holtz, Mats Wikström, R C Brasch, David L. White and Michael E. Moseley and has published in prestigious journals such as SHILAP Revista de lepidopterología, Radiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Pål Rongved

34 papers receiving 700 citations

Peers

Pål Rongved
Weixuan Chen United States
Sreeman Mamidyala United States
Edmund J. Moran United States
Pradeep K. Dhal United States
Allan B. Gamble New Zealand
Pål Rongved
Citations per year, relative to Pål Rongved Pål Rongved (= 1×) peers Charles Z. Ding

Countries citing papers authored by Pål Rongved

Since Specialization
Citations

This map shows the geographic impact of Pål Rongved's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pål Rongved with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pål Rongved more than expected).

Fields of papers citing papers by Pål Rongved

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pål Rongved. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pål Rongved. The network helps show where Pål Rongved may publish in the future.

Co-authorship network of co-authors of Pål Rongved

This figure shows the co-authorship network connecting the top 25 collaborators of Pål Rongved. A scholar is included among the top collaborators of Pål Rongved based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pål Rongved. Pål Rongved is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rongved, Pål, Geir Kildahl‐Andersen, Ragnar Hovland, et al.. (2025). APC24-7, a covalent combination of boronic acid and chelator moieties, restores β-lactam efficiency against metallo-β-lactamase-producers. mSphere. 10(12). e0041825–e0041825.
2.
Krishna, Vagolu Siva, Reidun Aesöy, Maonian Xu, et al.. (2025). Functionalized regioisomers of the natural product phenazines myxin and iodinin as potent inhibitors of Mycobacterium tuberculosis and human acute myeloid leukemia cells. European Journal of Medicinal Chemistry. 285. 117244–117244.
3.
Samuelsen, Ørjan, Christopher Fröhlich, Adam Heikal, et al.. (2020). ZN148 Is a Modular Synthetic Metallo-β-Lactamase Inhibitor That Reverses Carbapenem Resistance in Gram-Negative Pathogens In Vivo. Antimicrobial Agents and Chemotherapy. 64(6). 25 indexed citations
4.
Issa, Samar, et al.. (2019). Carbazole scaffolds in cancer therapy: a review from 2012 to 2018. Journal of Enzyme Inhibition and Medicinal Chemistry. 34(1). 1321–1346. 120 indexed citations
5.
Kildahl‐Andersen, Geir, Marc Le Borgne, Lars Petter Jordheim, et al.. (2019). Synthesis and biological evaluation of zinc chelating compounds as metallo-β-lactamase inhibitors. MedChemComm. 10(4). 528–537. 12 indexed citations
6.
Peeters, Sara, et al.. (2019). Cyclopropanation–ring expansion of 3-chloroindoles with α-halodiazoacetates: novel synthesis of 4-quinolone-3-carboxylic acid and norfloxacin. Beilstein Journal of Organic Chemistry. 15. 2156–2160. 26 indexed citations
7.
Brandtzaeg, Ole Kristian, et al.. (2019). Investigating Monoliths (Vinyl Azlactone-co-Ethylene Dimethacrylate) as a Support for Enzymes and Drugs, for Proteomics and Drug-Target Studies. Frontiers in Chemistry. 7. 835–835. 5 indexed citations
8.
Kildahl‐Andersen, Geir, Marc Le Borgne, Tor Gjøen, et al.. (2018). Synthesis and Preclinical Evaluation of TPA-Based Zinc Chelators as Metallo-β-lactamase Inhibitors. ACS Infectious Diseases. 4(9). 1407–1422. 41 indexed citations
9.
Herfindal, Lars, et al.. (2018). Enhancement of iodinin solubility by encapsulation into cyclodextrin nanoparticles. Journal of Enzyme Inhibition and Medicinal Chemistry. 33(1). 370–375. 7 indexed citations
10.
Aesöy, Reidun, et al.. (2017). Total synthesis and antileukemic evaluations of the phenazine 5,10-dioxide natural products iodinin, myxin and their derivatives. Bioorganic & Medicinal Chemistry. 25(7). 2285–2293. 26 indexed citations
11.
Sylte, Ingebrigt, et al.. (2016). Regulation of liver X receptor target genes by 22-functionalized oxysterols. Synthesis, in silico and in vitro evaluations. Steroids. 118. 119–127. 8 indexed citations
13.
Sylte, Ingebrigt, et al.. (2014). Development of new LXR modulators that regulate LXR target genes and reduce lipogenesis in human cell models. European Journal of Medicinal Chemistry. 74. 258–263. 8 indexed citations
14.
Rongved, Pål, Gilbert Kirsch, Zouhair Bouaziz, Joachim Jose, & Marc Le Borgne. (2013). Indenoindoles and cyclopentacarbazoles as bioactive compounds: Synthesis and biological applications. European Journal of Medicinal Chemistry. 69. 465–479. 43 indexed citations
15.
16.
Klaveness, Jo, et al.. (2011). N-(tert-Butoxycarbonyl)-L-valyl-L-valine methyl ester: a twisted parallel β-sheet in the crystal structure of a protected dipeptide. Acta Crystallographica Section C Crystal Structure Communications. 67(8). o278–o282. 6 indexed citations
17.
Bruheim, Skjalg, Gunhild M. Mælandsmo, Dag Erlend Olberg, et al.. (2009). Didanosine ester prodrugs: Synthesis, albumin binding properties and pharmacokinetic studies in rats. European Journal of Medicinal Chemistry. 44(10). 3874–3879. 5 indexed citations
18.
Klaveness, Jo, et al.. (2009). Synthesis of cyclic peptide analogues of the 310 helical Pro138-Gly144 segment of human aquaporin-4 by olefin metathesis. Organic & Biomolecular Chemistry. 7(8). 1599–1599. 21 indexed citations
19.
Fossheim, Sigrid L., et al.. (1997). Low molecular weight lanthanide contrast agents: In vitro studies of mechanisms of action. Journal of Magnetic Resonance Imaging. 7(1). 251–257. 13 indexed citations
20.
Wikström, Mats, David L. White, Jo Klaveness, et al.. (1990). Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues.. Radiology. 175(2). 483–488. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026